I specialise in reproductive genomics and genomic instability across biological systems relevant to human health.

I have extensive expertise in chromosomal abnormalities and how they can affect human development and disease. In clinical diagnostics, my expertise focuses in preimplantation genetic testing of human embryos and gametes and genetic investigations for couples that were experiencing infertility for various reasons and for carriers of rare chromosomal abnormalities like translocations, ring chromosomes and deletions. 

My research focuses on understanding how chromosomal abnormalities, sequence variation, and environmental factors interact to influence reproductive health, early human development.

My work integrates molecular genetics and cytogenetics, whole-genome sequencing, and bioinformatics to investigate genomic instability in human embryos and gametes. Through collaborations with clinical and research partners, I analyse large genomic datasets to identify pathogenic variants associated with reproductive disorders, including recurrent pregnancy loss, unexplained infertility, recurrent IVF failure, and endometriosis, as well as broader questions relating to early human embryo genomics.

My research also extends to microbial genomics and antimicrobial resistance (AMR), using genomic approaches to study clinically significant pathogens and understand the genetic instability mechanisms underlying the emergence and spread of antimicrobial resistance. My AMR work has received funding Pfizer and the NIHR, and I have contributed to national genomic initiatives such as the COVID-19 Genomics UK (COG-UK) Consortium.

Alongside my research, I am actively involved in advancing bio-medical science education, developing research-embedded teaching approaches, practical laboratory training, and innovative methods for teaching genomic data analysis.